ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...
ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...
New kidney treatment techniques achieved impressive results in some studies, with one method showing 71% kidney recovery ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...
New research has identified how a misstep in the genesis of a key component of the kidney causes infantile cystinosis, a rare disease that significantly shortens the lifespan of patients. The work ...
Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is ...
Kidney disease is a silent killer, and unlike heart disease and cancer, the symptoms often appear very late. Our study from SGPGI Lucknow in 1999 was among the earliest to show that diabetes (which ...
DUARTE, Calif. -- It's hair-raising research as scientists say riding a roller coaster might be a cure for kidney stones. Big Thunder Mountain Railroad is a runaway mine train adventure, but for ...
News-Medical.Net on MSN
Study reveals innate immune barriers to long-term pig kidney transplant survival
Pioneering research led by Brazilians describes the immune system's reactions in detail in the first living patient to receive a genetically modified pig kidney transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results